The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells
Molecular Cancer Therapeutics, ISSN: 1538-8514, Vol: 12, Issue: 11, Page: 2483-2493
2013
- 28Citations
- 33Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations28
- Citation Indexes27
- 27
- CrossRef26
- Policy Citations1
- Policy Citation1
- Captures33
- Readers33
- 33
Article Description
2,3-Dihydro-5-methyl-3-([morpholinyl]methyl)pyrollo(1,2,3-de)-1,4-benzoxazinyl]-[1-naphthaleny]methanone [WIN 55,212-2, (WIN)] is a synthetic cannabinoid that inhibits RKO, HT-29, and SW480 cell growth, induced apoptosis, and downregulated expression of survivin, cyclin D1, EGF receptor (EGFR), VEGF, and its receptor (VEGFR1). WIN also decreased expression of specificity protein (Sp) transcription factors Sp1, Sp3, and Sp4, and this is consistent with the observed downregulation of the aforementioned Sp-regulated genes. In addition, we also observed by RNA interference (RNAi) that the oncogenic cap protein eIF4E was an Sp-regulated gene also downregulated by WIN in colon cancer cells. WIN-mediated repression of Sp proteins was not affected by cannabinoid receptor antagonists or by knockdown of the receptor but was attenuated by the phosphatase inhibitor sodium orthovanadate or by knockdown of protein phosphatase 2A (PP2A). WIN-mediated repression of Sp1, Sp3, and Sp4 was due to PP2A-dependent downregulation of microRNA-27a (miR-27a) and induction of miR-27a-regulated ZBTB10, which has previously been characterized as an "Sp repressor." The results show that the anticancer activity of WIN is due, in part, to PP2A-dependent disruption of miR-27a:ZBTB10 and ZBTB10-mediated repression of Sp transcription factors and Sp-regulated genes, including eIF4E. Mol Cancer Ther; 12(11); 2483-93. © 2013 AACR.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84887459745&origin=inward; http://dx.doi.org/10.1158/1535-7163.mct-13-0486; http://www.ncbi.nlm.nih.gov/pubmed/24030632; https://aacrjournals.org/mct/article/12/11/2483/91480/The-Cannabinoid-WIN-55-212-2-Decreases-Specificity; http://mct.aacrjournals.org/cgi/doi/10.1158/1535-7163.MCT-13-0486; https://syndication.highwire.org/content/doi/10.1158/1535-7163.MCT-13-0486; https://dx.doi.org/10.1158/1535-7163.mct-13-0486; http://mct.aacrjournals.org/lookup/doi/10.1158/1535-7163.MCT-13-0486; http://mct.aacrjournals.org/content/12/11/2483; http://mct.aacrjournals.org/content/12/11/2483.abstract; http://mct.aacrjournals.org/content/12/11/2483.full.pdf; https://mct.aacrjournals.org/content/12/11/2483; https://mct.aacrjournals.org/content/12/11/2483.abstract; https://mct.aacrjournals.org/content/molcanther/12/11/2483.full.pdf
American Association for Cancer Research (AACR)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know